Mark E. Robson

MedicineBiochemistry, Genetics and Molecular BiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

5.2Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab124

Top 4%

5.0DataRank

Top 4%199 citations

Walid K. Chatila, Rona Yaeger, Henry Walch, Gustavo dos Santos Fernandes, Asha Krishnan +42 more

Papers

Driven by 62 papers — median percentile 21. Top paper: “A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers”.

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab124

Top 4%

5.0DataRank

Top 4%199 citations

Walid K. Chatila, Rona Yaeger, Henry Walch, Gustavo dos Santos Fernandes, Asha Krishnan +42 more

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

The Lancet(2023)10.1016/s0140-6736(23)01857-3

N/A

4.7DataRank · unranked

264 citations

Jonathan T. Yang, Juber Patel, Annemarie F. Shepherd, Juliana Eng, Randy Yeh +44 more

Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency

Fertility and Sterility(2020)10.1016/j.fertnstert.2020.01.033

N/A

2.1DataRank · unranked

73 citations

Giuliano Bedoschi, Shari Goldfarb, Enes Taylan, Shiny Titus, Glenn E. Palomaki +4 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Nature Genetics(2020)10.1038/s41588-020-00710-0

N/A

0.993DataRank · unranked

750 citations

Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin, Daniel J. Kelly +59 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa030

N/A

0.769DataRank · unranked

168 citations

Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber +56 more

Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa048

N/A

0.626DataRank · unranked

64 citations

Wanqing Iris Zhi, Raymond E. Baser, Madeline J. Hooper, Connie Chen, Lauren Piulson +8 more

Functional evaluation and clinical classification of BRCA2 variants

Nature(2025)10.1038/s41586-024-08388-8

N/A

0.606DataRank · unranked

56 citations

Chunling Hu, Jie Na, Steven N. Hart, Rohan Gnanaolivu, Mohamed Abozaid +39 more

Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing

Annals of Oncology(2022)10.1016/j.annonc.2022.01.006

N/A

0.604DataRank · unranked

55 citations

Fresia Pareja, David N. Brown, Ozge Ceyhan‐Birsoy, Maksym Misyura, Satshil Rana +16 more

Protein-altering germline mutations implicate novel genes related to lung cancer development

Nature Communications(2020)10.1038/s41467-020-15905-6

N/A

0.587DataRank · unranked

49 citations

Semanti Mukherjee, Maria Teresa Landi, Yohan Bossé, Philippe Joubert, Dakai Zhu +95 more

Electro-acupuncture versus battle field auricular acupuncture in breast cancer survivors with chronic musculoskeletal pain: subgroup analysis of a randomized clinical trial

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07072-1

N/A

0.573DataRank · unranked

12 citations

Wanqing Iris Zhi, Raymond E. Baser, Q. Susan Li, Matthew Weitzman, Erin F. Gillespie +3 more

Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants

Cancer(2022)10.1002/cncr.34434

N/A

0.571DataRank · unranked

44 citations

Anna Maio, Yelena Kemel, Erin Salo‐Mullen, Margaret Sheehan, Prince Ray Tejada +22 more

Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa031

N/A

0.542DataRank · unranked

36 citations

Mark E. Robson, Lene Mellemkjær, Marc Tischkowitz, Esther M. John, Charles F. Lynch +20 more

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1287

N/A

0.524DataRank · unranked

32 citations

Chaitanya Bandlamudi, Matthew D. Hellmann, Yelena Kemel, Esther Drill, Hira Rizvi +32 more

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1006

N/A

0.416DataRank · unranked

15 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer

Research Square(2024)10.21203/rs.3.rs-4244833/v1

N/A

0.378DataRank · unranked

7 citations

David A. Knorr, Polina Weitzenfeld, Ning Yao, Maria Baez, M Dilillo +7 more

Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

Cancer Medicine(2023)10.1002/cam4.6272

N/A

0.360DataRank · unranked

10 citations

Maartje A. C. Schreurs, Irene L. Andrulis, Hoda Anton‐Culver, Annelie Augustinsson, Matthias W. Beckmann +95 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.14.571597

N/A

0.269DataRank · unranked

5 citations

Chunling Hu, Jie Na, Steven N. Hart, Rohan Gnanaolivu, Mohamed Abozaid +18 more

Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00816-w

N/A

0.208DataRank · unranked

3 citations

Fresia Pareja, Charlie White, Yuan Chen, Hannah Y. Wen, Esra Dikoglu +11 more

Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07127-3

N/A

0.152DataRank · unranked

1 citations

Edi Brogi, Donna M. Thompson, Victoria Blinder, Larry Norton, Monica Morrow +3 more

The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in BRCA1/2 Carriers

medRxiv(2025)10.1101/2025.11.10.25339918

N/A

0.104DataRank · unranked

1 citations

C.M. Salafia, Rania Sheikh, Elizabeth Schofield, Dana Clark, Jessica Ebrahimzadeh +16 more

Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor–positive breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12100

N/A

0DataRank · unranked

2 citations

Alexander Pan, George Dranitsaris, Ucalene Harris, Sarat Chandarlapaty, Chau T. Dang +11 more

OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

European Journal of Cancer(2023)10.1016/j.ejca.2023.01.031

N/A

0DataRank · unranked

113 citations

Seock‐Ah Im, Elżbieta Senkus, Binghe Xu, Susan M. Domchek, Norikazu Masuda +8 more

Comprehensive analysis of germline drivers in endometrial cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad016

N/A

0DataRank · unranked

21 citations

Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel +37 more

Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease

Annals of Surgical Oncology(2023)10.1245/s10434-023-14141-8

N/A

0DataRank · unranked

10 citations

Carlos Henrique dos Anjos, Varadan Sevilimedu, Angelena Crown, K. Amoroso, Melissa Pilewskie +3 more

Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer

Annals of Surgical Oncology(2023)10.1245/s10434-023-14319-0

N/A

0DataRank · unranked

7 citations

Varadan Sevilimedu, Andrea V. Barrio, Audree B. Tadros, Anita Mamtani, Mark E. Robson +3 more

Development of a novel measure of advanced cancer patients’ perceived utility of secondary germline findings from tumor genomic profiling

PEC Innovation(2023)10.1016/j.pecinn.2023.100124

N/A

0DataRank · unranked

4 citations

Ibrahim H. Shah, C.M. Salafia, Elizabeth Schofield, Margaux Genoff Garzon, Kechna Cadet +5 more

Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad129

N/A

0DataRank · unranked

1 citations

Mark E. Robson, Minna K. Lee

HER2 persistence after treatment with T-DXd in breast and gastrointestinal cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1052

N/A

0DataRank · unranked

6 citations

Fresia Pareja, Komal Jhaveri, Elaine M. Walsh, Geoffrey Y. Ku, Steven B. Maron +7 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038

Top 100%

0DataRank

Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Data from Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome

(2023)10.1158/1078-0432.c.6530810

Top 100%

0DataRank

Top 100%0 citations

Edaise M. da Silva, Antonio Marra, Andrea Gazzo, Pier Selenica, K. Vikas +16 more

Data from Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report

(2023)10.1158/1078-0432.c.6519293.v1

N/A

0DataRank · unranked

0 citations

Emil Lou, Christopher G. Azzoli, Rekha Reddy, Mark E. Robson, Megan Harlan +12 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764.v1

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants

Research Square(2023)10.21203/rs.3.rs-3736200/v1

N/A

0DataRank · unranked

0 citations

Huaizhi Huang, Chunling Hu, Jie Na, Steven N. Hart, Rohan Gnanaolivu +18 more

Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer

Cancer Cell(2025)10.1016/j.ccell.2025.07.013

N/A

0DataRank · unranked

30 citations

David A. Knorr, Polina Weitzenfeld, Lucas Blanchard, Ning Yao, Maria Baez +10 more

Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group

Cancer Treatment Reviews(2025)10.1016/j.ctrv.2025.103001

N/A

0DataRank · unranked

13 citations

Sherry Shen, Carmen Criscitiello, Rita A. Mukhtar, Lauren A. Gamble, Elena Guerini‐Rocco +20 more

Data from Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report

(2023)10.1158/1078-0432.c.6519293

N/A

0DataRank · unranked

0 citations

Emil Lou, Christopher G. Azzoli, Rekha Reddy, Mark E. Robson, Megan Harlan +12 more

Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0418

N/A

0DataRank · unranked

227 citations

Jiapeng Chen, Joanne F. Chou, Anna M. Varghese, Kenneth H. Yu, Winston Wong +26 more

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action

JCI Insight(2020)10.1172/jci.insight.137571

N/A

0DataRank · unranked

45 citations

James N. Ingle, Tanda M. Dudenkov, Krishna R. Kalari, Erin E. Carlson, Jie Na +12 more

The genomic landscape of metastatic histologic special types of invasive breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-00195-4

N/A

0DataRank · unranked

48 citations

Lorenzo Ferrando, Simon Lee, Francisco Beça, Pier Selenica, David N. Brown +13 more

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Annals of Surgical Oncology(2020)10.1245/s10434-019-08039-7

N/A

0DataRank · unranked

26 citations

Susanne Wagner, Darl D. Flake, Mark E. Robson, Lee S. Schwartzberg, Priyanka Sharma +7 more

Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1527

N/A

0DataRank · unranked

1 citations

Erin Salo‐Mullen, Amanda Catchings, Megha Ranganathan, Elise Fiala, Yelena Kemel +15 more

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

UNC Libraries(2020)10.17615/dy70-ej71

N/A

0DataRank · unranked

0 citations

Kay‐Tee Khaw, Mark E. Robson, Diether Lambrechts, Janna Lilyquist, Emily Hallberg +95 more

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma

npj Breast Cancer(2021)10.1038/s41523-021-00302-z

N/A

0DataRank · unranked

89 citations

Edi Brogi, Jorge S. Reis‐Filho, George Plitas, Mark E. Robson, Larry Norton +3 more

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing

European Urology Oncology(2021)10.1016/j.euo.2021.09.005

N/A

0DataRank · unranked

39 citations

Rania Sheikh, Ritesh R. Kotecha, Yelena Kemel, Peter A. Reisz, Andrew T. Lenis +22 more

Cancer-Causative Mutations Occurring in Early Embryogenesis

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1110

N/A

0DataRank · unranked

36 citations

Ryan Ptashkin, David N. Brown, Fatemeh Derakhshan, Pier Selenica, Edaise M. da Silva +31 more

Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2027

N/A

0DataRank · unranked

31 citations

Edaise M. da Silva, Antonio Marra, Andrea M. Gazzo, Pier Selenica, Vikas K. Rai +16 more

Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination

npj Breast Cancer(2021)10.1038/s41523-021-00339-0

N/A

0DataRank · unranked

28 citations

Pier Selenica, Semanti Mukherjee, Rachna Shah, Isabella L. Pecorari, Biko McMillan +16 more

Penetrance of male breast cancer susceptibility genes: a systematic review

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06413-2

N/A

0DataRank · unranked

24 citations

Cathy Wang, Kanhua Yin, Jin Wang, Preeti Singh, Jingan Zhou +4 more

Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab117

N/A

0DataRank · unranked

19 citations

Pier Selenica, M. Herman Chui, Gowtham Jayakumaran, Ryan Ptashkin, Maksym Misyura +20 more

Tolerability of Breast Radiotherapy Among Carriers of ATM Germline Variants

JCO Precision Oncology(2021)10.1200/po.20.00334

N/A

0DataRank · unranked

11 citations

Jessica Flynn, Zhigang Zhang, Oren Cahlon, Boris Mueller, Atif J. Khan +7 more

Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.006

N/A

0DataRank · unranked

5 citations

Silvana Pedra Nobre, Nisha Pradhan, Maya Yasukawa, Qin Zhou, Alexia Iasonos +11 more

Breast cancer screening for carriers of ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10500

N/A

0DataRank · unranked

3 citations

H. Amarens Geuzinge, Natasha K. Stout, Oğuzhan Alagöz, John M. Hampton, Karla Kerlikowske +15 more

Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5022

N/A

0DataRank · unranked

1 citations

Kelsey Breen, Yelena Kemel, Andrew T. Lenis, Peter A. Reisz, Nicole Benfante +15 more

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion

Journal of Clinical Oncology(2022)10.1200/jco.21.02767

N/A

0DataRank · unranked

255 citations

Amber M. Johnson, Jeffrey Sklar, Neal I. Lindeman, Kathleen N. Moore, Shridar Ganesan +13 more

Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

Genome Medicine(2022)10.1186/s13073-022-01101-2

N/A

0DataRank · unranked

45 citations

Gowtham Jayakumaran, Yelena Kemel, Maksym Misyura, Umut Aypar, Sowmya Jairam +20 more

Deep Interactive Learning-based ovarian cancer segmentation of H&E-stained whole slide images to study morphological patterns of BRCA mutation

Journal of Pathology Informatics(2022)10.1016/j.jpi.2022.100160

N/A

0DataRank · unranked

36 citations

M. Herman Chui, Chad Vanderbilt, Ji‐Won Jung, Mark E. Robson, Chan-Sik Park +3 more

Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy

Annals of Surgical Oncology(2022)10.1245/s10434-022-11756-1

N/A

0DataRank · unranked

24 citations

Varadan Sevilimedu, Elizabeth R. Berger, Mark E. Robson, Alexandra S. Heerdt, Melissa Pilewskie +1 more

Testing for Inherited Susceptibility to Breast Cancer

Hematology/Oncology Clinics of North America(2022)10.1016/j.hoc.2022.08.003

N/A

0DataRank · unranked

6 citations

Mark E. Robson

Mark E. Robson

Indexed papers

Top data-sharing exemplar

Papers